Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma

Clinical trial NCT02141347 · COMPLETED

Trial details

NCT number: NCT02141347
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Part A and B: Advanced Solid Malignancies Part C: Malignant Mesothelioma

Start date: 2014-05-22
Primary completion: 2017-01-27
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.